Abstract

Clinical case series describes a contraindication for SerenoCem Granules™ in mastoid obliteration: Our experience in sixty-four patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call